MOUNTAIN VIEW, Calif., March 26 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development announced today that it will be presenting at B. Riley & Co. 9th Annual Las Vegas Investor Conference on April 2, 2008 at the Palms Las Vegas. Shawn O'Connor, Pharsight's President and CEO, and William Frederick, Senior Vice President and CFO, will be presenting on April 2nd, at 1:30 p.m. PT.
Attendance at the conference is by invitation only. A live audio webcast of the presentation with slides will be broadcast via the Internet. The webcast can be viewed at the company's website under the investor relations section at http://www.pharsight.com.
About Pharsight Corporation
Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.
Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com
|SOURCE Pharsight Corporation|
Copyright©2008 PR Newswire.
All rights reserved